|
|
|
Volumn 26, Issue 2 SUUPL., 1999, Pages 99-104
|
|
Overview of phase II trials of MTA in solid tumors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIHYDROFOLATE REDUCTASE;
PEMETREXED;
PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE;
THYMIDINE;
THYMIDYLATE SYNTHASE;
BLADDER CANCER;
BREAST CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
DIGESTIVE SYSTEM CANCER;
DISTRIBUTION VOLUME;
DOSE TIME EFFECT RELATION;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG HALF LIFE;
ENZYME INHIBITION;
GASTROINTESTINAL TOXICITY;
GYNECOLOGIC CANCER;
HEAD AND NECK CANCER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PURINE SYNTHESIS;
RASH;
REVIEW;
SOLID TUMOR;
SQUAMOUS CELL CARCINOMA;
THROMBOCYTOPENIA;
UROGENITAL TRACT CANCER;
UTERINE CERVIX CANCER;
ANTIMETABOLITES, ANTINEOPLASTIC;
BREAST NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II;
ENZYME INHIBITORS;
FEMALE;
FOLIC ACID ANTAGONISTS;
GASTROINTESTINAL NEOPLASMS;
GENITAL NEOPLASMS, FEMALE;
GLUTAMATES;
GUANINE;
HEAD AND NECK NEOPLASMS;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOPLASMS;
THYMIDYLATE SYNTHASE;
UROGENITAL NEOPLASMS;
|
|
EID: 0032965322
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (31)
|
|
References (16)
|
